Non-calcemic, antiproliferative, transcriptionally active 24-flu

Organic compounds -- part of the class 532-570 series – Organic compounds – 9,10-seco-cyclopentanohydrophenanthrene ring system or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

552653, 514167, C07C40100, A61K 3159

Patent

active

060433868

ABSTRACT:
Fluorinated analogs of 1.alpha.,25-dihydroxyvitamin D.sub.3. These analogs are synthesized in a convergent manner by joining A-ring and C,D-ring fragments. Each hybrid analog, having a calcemia-lowering 1-hydroxymethyl group and a potentiating 16-ene-24,24-difluorinated C,D-ring and side chain, is designed to be lipophilic and inert toward 24-hydroxylase enzyme catabolism. Each hybrid analog with 1.beta.,3.alpha.-substituent stereochemistry shows a pharmacologically desirable combination of high antiproliferative and high transcriptional activities in vitro and also low calcemic activity in vivo.

REFERENCES:
patent: 4421690 (1983-12-01), Partridge et al.
patent: 4599330 (1986-07-01), Boris et al.
patent: 4853378 (1989-08-01), Hamma et al.
patent: 4868165 (1989-09-01), Ikekawa
patent: 4970203 (1990-11-01), DeLuca et al.
patent: 5830885 (1998-11-01), Posner
Vanham et al. (J. Steroid Chem. Biochem. (1988), 29(4), 381-6), 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Non-calcemic, antiproliferative, transcriptionally active 24-flu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-calcemic, antiproliferative, transcriptionally active 24-flu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-calcemic, antiproliferative, transcriptionally active 24-flu will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1327031

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.